Cardio3 BioSciences announces acquisition of CorQuest Medical Cardio3 BioSciences generisk priligy.

Cardio3 BioSciences announces acquisition of CorQuest Medical Cardio3 BioSciences , a leader in the development and discovery of regenerative, protective and reconstructive therapies, today that it has acquired U announces.S.-based CorQuest Medical Inc generisk priligy . CorQuest Medical specializes in the advancement of innovative systems and products for cardiac surgery. CorQuest's groundbreaking technology is designed to enable cardiologists to take a unique access route directly to the patient's left atrium and therefore has the potential to become major breakthrough innovation for therapeutic indications such as mitral valve disorders and structural cardiovascular disease, conditions often associated with heart failure.

Artificial bone scaffolds have already been made from a wide variety of materials, such as peptide or polymers fibers, but they have a true number of drawbacks, including low power and the prospect of rejection in the physical body. Compared with these scaffolds, the high mechanical power, excellent flexibility and low density of carbon nanotubes make sure they are ideal for the production of lightweight, high-strength components such as for example bone, says Robert Haddon, Ph.D., a chemist at the University of California, Riverside, and business lead writer of the paper. Single-walled carbon nanotubes are a occurring type of carbon, like graphite or diamond, where the atoms are arranged just like a rolled-up tube of chicken wire. They are among the strongest known components in the world.